ZoomMed

ZoomMed is a Canadian healthcare technology company specializing in the development of electronic clinical information systems. The company's flagship product, the ZRx Prescriber, is a web-based mobile platform that allows physicians to write and transmit prescriptions electronically to pharmacies. This technology aims to reduce medication errors, improve patient safety, and streamline the communication between healthcare providers and pharmacists. In addition to e-prescribing, ZoomMed provides clinical decision support tools and communication solutions for the pharmaceutical industry. The company's core assets were acquired by KDA Group in 2021 to strengthen its digital health and pharmacy service offerings.